An optimal NSTEMI/unstable angina management algorithm maximizes the anticoagulant benefit of pharmacological agents, employs coronary intervention when indicated, while simultaneously minimizing bleeding risks.  Recent trials (OASIS, ACUTIY etc.) have correlated reductions in bleeding events with improvements in outcomes of death, MI and stroke.  Reduction of bleeding complications has therefore become a priority in NSTEMI/unstable angina management.
Unstable angina / non ST elevation myocardial infarction complications of bleeding and transfusion prevention
Unstable angina / non ST elevation myocardial infarction complications of bleeding and transfusion recommendations
Unstable angina / non ST elevation myocardial infarction complications of bleeding and transfusion prognosis
Unstable angina / non ST elevation myocardial infarction complications of bleeding and transfusion - blood transfusions
Unstable angina / non ST elevation myocardial infarction complications of bleeding and transfusion - definitions for bleeding complications
Unstable angina / non ST elevation myocardial infarction complications of bleeding and transfusion - predictors and causes of bleeding
Heparin-induced thrombocytopenia future or investigational therapies
Heparin-induced thrombocytopenia primary prevention